Unum Group – Consensus ‘buy’ rating and 28.1% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Unum Group with ticker code (UNM) have now 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $61.00 and $45.00 with the average target price sitting at $54.00. Given that the stocks previous close was at $42.17 this would imply there is now a potential upside of 28.1%. Also worth taking note is the 50 day moving average now sits at $46.81 while the 200 day moving average is $45.45. The company has a market capitalization of 8.26B. The current share price for the company is: $42.36 USD

The potential market cap would be $10,579,938,934 based on the market consensus.

The company has a dividend yield of 3.08%. Other points of data to note are a P/E ratio of 7.32, revenue per share of $61.99 and a 1.72% return on assets.

Unum Group is a provider of workplace benefits and services. The Company provides financial protection benefits in the United States and the United Kingdom. Its products include disability, life, accident, critical illness, dental and vision, and other related services. It markets its products primarily through the workplace. The Company has three segments: Unum US, Unum International, and Colonial Life. The Unum US segment is comprised of group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. The Unum International segment includes its operations in the United Kingdom and Poland. The segment’s products are sold primarily through field sales personnel and independent brokers and consultants. The Colonial Life segment includes accident, sickness and disability products, life products, and cancer and critical illness products. The segment’s products are issued primarily by Colonial Life & Accident Insurance Company.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search